Alpha 2.0
Login Register
» Articles » PMID: 38757285

Increase in Invasive Group A Streptococcal Infections (iGAS) in Children and Older Adults, Norway, 2022 to 2024

Overview
Journal Euro Surveill
Specialty Infectious Diseases
Date 2024 May 17
PMID 38757285
Authors
Beatriz Valcarcel Salamanca
Pascale Renee Cyr
Yngvild Emblem Bentdal
Sara Viksmoen Watle
Astrid Louise Wester
Ase Marie Wikman Strand
Hakon Boas
Affiliations
Soon will be listed here.
Abstract

At the end of 2022 and most notably during the first half of 2023, the number of invasive group A streptococcus (iGAS) notifications increased in Norway, largely affecting children younger than 10 years, as observed in several other countries. Following this atypical season, a new surge in the number of iGAS notifications began in December 2023 and peaked between January and February 2024, now particularly affecting both children younger than 10 years and older adults (70 years and above).

Citing Articles

Characterization of Strains from Tonsillopharyngitis and Scarlet Fever Resurgence, 2023-FIRST Detection of M1 in Bulgaria.

Keuleyan E, Todorov T, Donchev D, Kevorkyan A, Vazharova R, Kukov A Microorganisms. 2025; 13(1).

PMID: 39858946 PMC: 11767604. DOI: 10.3390/microorganisms13010179.

Impact of the SARS-CoV-2 Pandemic on the Epidemiology of : A Five-Year Retrospective Study.

Branas P, Fontenla F, Castano-Amores M, Recio R, Munoz-Gallego I, Villa J Microorganisms. 2025; 12(12.

PMID: 39770606 PMC: 11676829. DOI: 10.3390/microorganisms12122403.

Group A Streptococcus Infections in Children: Epidemiological Insights Before and After the COVID-19 Pandemic.

Karapati E, Tsantes A, Iliodromiti Z, Boutsikou T, Paliatsiou S, Domouchtsidou A Pathogens. 2024; 13(11).

PMID: 39599560 PMC: 11597688. DOI: 10.3390/pathogens13111007.

Two Cases of Group A Streptococcus-Induced Right Empyema: Rare Occurrences in Adult Medicine.

Leung C, Fong P, Chan Y, Ho M, Yeung Y Cureus. 2024; 16(9):e68920.

PMID: 39381458 PMC: 11459252. DOI: 10.7759/cureus.68920.

Ongoing Excess Hospitalizations for Severe Pediatric Group A Streptococcal Disease in 2023-2024-A Single-Center Report.

Schobi N, Duppenthaler A, Horn M, Bartenstein A, Keitel K, Kopp M Infect Dis Rep. 2024; 16(5):864-869.

PMID: 39311208 PMC: 11417816. DOI: 10.3390/idr16050067.

References
1.
Abo Y, Oliver J, McMinn A, Osowicki J, Baker C, Clark J . Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges. Lancet Reg Health West Pac. 2024; 41:100873. PMC: 10786649. DOI: 10.1016/j.lanwpc.2023.100873. View
2.
Yin K, Peluso M, Luo X, Thomas R, Shin M, Neidleman J . Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. 2024; 25(2):218-225. PMC: 10834368. DOI: 10.1038/s41590-023-01724-6. View
3.
Aboulhosn A, Sanson M, Vega L, Segura M, Summer L, Joseph M . Increases in group A streptococcal infections in the pediatric population in Houston, TX, 2022. Clin Infect Dis. 2023; . PMC: 10425190. DOI: 10.1093/cid/ciad197. View
4.
Guy R, Henderson K, Coelho J, Hughes H, Mason E, Gerver S . Increase in invasive group A streptococcal infection notifications, England, 2022. Euro Surveill. 2023; 28(1). PMC: 9817207. DOI: 10.2807/1560-7917.ES.2023.28.1.2200942. View
5.
Martin P, Hoiby E . Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis. 1990; 22(4):421-9. DOI: 10.3109/00365549009027073. View